Elite Pharmaceuticals Inc (ELTP): 1. Our revenue is not at risk. 2. A...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Monday, 10/03/2022 10:08:57 PM

Monday, October 03, 2022 10:08:57 PM

1. Our revenue is not at risk.

2. Adderall IR & XR is around 70% of our current revenues.

3. Nasrat already stated the plan during the last CC.

85% of our revenue is at risk and we haven’t heard a plan from Nasrat.

----------------------------------------------------------------------------------------------------------------------------------

MAKE ELITE GREAT AGAIN!

Keep Last Read

Replies (2) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM

InvestorsHub NewsWire

Only $200 per official company press release!